Terminal ileum thickness during maintenance therapy is a predictive marker of the outcome of infliximab therapy in crohn disease

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Terminal ileum thickness during maintenance therapy is a predictive marker of the outcome of infliximab therapy in crohn disease'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science